| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $79,845,306 ) (Continued on the next page) |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21CA281031 | Utilizing tobacco discrete choice experiments to predict the population impacts of FDA regulatory policies | 000 | 2 | NIH | 4/12/2024 | $186,834 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K08DC020761 | Engineering protease biomarkers to guide surgical therapy for vestibular schwannoma and Neurofibromatosis Type 2 | 000 | 2 | NIH | 1/5/2024 | $191,561 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA279965 | Endoscopic Ultrasound-guided In Vivo Confocal Laser Endomicroscopy as an Imaging Biomarker for the Accurate Risk Stratification of Intraductal Papillary Mucinous Neoplasms | 001 | 2 | NIH | 4/17/2024 | $21,939 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA279965 | Endoscopic Ultrasound-guided In Vivo Confocal Laser Endomicroscopy as an Imaging Biomarker for the Accurate Risk Stratification of Intraductal Papillary Mucinous Neoplasms | 000 | 2 | NIH | 3/18/2024 | $394,895 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA270251 | A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL | 001 | 2 | NIH | 4/15/2024 | $21,699 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA270251 | A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL | 000 | 2 | NIH | 11/29/2023 | $390,578 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21AI174093 | The effect of the microbiota on male Aedes aegypti life history traits | 000 | 2 | NIH | 10/26/2023 | $177,188 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21CA271070 | Developing a Patient Navigation Intervention to Improve Risk Management among Women at High Risk of Breast Cancer | 000 | 2 | NIH | 2/1/2024 | $165,671 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K01DA055696 | Effects of tobacco cut and nicotine form on the abuse liability of moist snuff | 000 | 2 | NIH | 1/3/2024 | $178,021 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K01AR080833 | Sensory neuron-skin interaction in health and disease | 001 | 2 | NIH | 2/2/2024 | $182,231 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01LM014385 | Generative AI for retrosynthesis libraries | 000 | 1 | NIH | 1/9/2024 | $330,713 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31CA288053 | Defining the biochemical properties and implications of NRAS mutant-specific BRAF interactions in melanoma | 000 | 1 | NIH | 3/14/2024 | $36,314 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R56AI181631 | Antagonize Host Survival and Immune Escape Mechanisms for Elimination of HIV Viral Reservoirs | 000 | 1 | NIH | 3/14/2024 | $758,970 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA287261 | Fecal microbial transplantation for chemotherapy behavioral side effects | 000 | 1 | NIH | 1/18/2024 | $615,068 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01AG080017 | Does Creating Person-specific Precision Thresholds Enhance the Ability of a Single Bone Density Measure to Predict Fractures in Minority Women? | 000 | 1 | NIH | 11/17/2023 | $644,541 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HD110503 | Prenatal Immunomonitoring in Spontaneous Preterm Birth Prevention (PROMIS) | 000 | 1 | NIH | 3/29/2024 | $443,883 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K08HL171895 | The Role of E3 Ligase MARCH10 in Influenza Virus Infection | 000 | 1 | NIH | 12/19/2023 | $165,024 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K99GM154061 | Investigating UPF3 paralog function in Nonsense-Mediated mRNA Decay and Genetic Compensation | 000 | 1 | NIH | 4/5/2024 | $110,151 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R13CA287389 | 33rd International Workshop on Retroviral Pathogenesis | 001 | 1 | NIH | 12/27/2023 | $5,000 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R13CA287389 | 33rd International Workshop on Retroviral Pathogenesis | 000 | 1 | NIH | 11/28/2023 | $5,000 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31AI181575 | Structure and function of a novel bacterial immune system | 000 | 1 | NIH | 3/21/2024 | $36,314 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | P01AI175399 | Role of the Non-canonical Inflammasome in SARS-CoV-2-mediated Pathology and Coagulopathy | 000 | 1 | NIH | 4/10/2024 | $3,046,145 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R61AG081982 | Development of an online mindfulness training program for adults with subjective cognitive decline | 000 | 1 | NIH | 3/29/2024 | $511,499 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01DK135948 | Development of a Group Emotion-Focused Behavioral Intervention for Diabetes Distress and Glycemic Management in Patients with T2D. | 000 | 1 | NIH | 1/31/2024 | $315,000 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH134121 | Orchestrating tryptophan metabolites to protect neurodevelopment from prenatal stress | 000 | 1 | NIH | 3/7/2024 | $662,621 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL171689 | Novel role for the spectrin cytoskeleton in regulation of cardiac fibroblast activity, long-range communication and injury-induced fibrosis | 000 | 1 | NIH | 12/1/2023 | $495,888 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K23HL168328 | Novel role of alpha-1 antitrypsin in monocyte-driven disease activity in ANCA-associated vasculitis | 000 | 1 | NIH | 3/5/2024 | $190,620 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K23HL168328 | Novel role of alpha-1 antitrypsin in monocyte-driven disease activity in ANCA-associated vasculitis | 001 | 1 | NIH | 3/13/2024 | $0 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL167963 | Right ventricle remodeling in pulmonary hypertension | 000 | 1 | NIH | 12/11/2023 | $453,242 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F32DC021844 | Patient-Reported Benefits of Cochlear Implant Listening Configurations | 001 | 1 | NIH | 12/12/2023 | $0 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F32DC021844 | Patient-Reported Benefits of Cochlear Implant Listening Configurations | 000 | 1 | NIH | 12/12/2023 | $81,967 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K08HL169725 | Transfer RNAs as novel mediators in acute lung injury | 000 | 1 | NIH | 4/19/2024 | $163,620 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | 2401OHATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 2 | 1 | ACL | 3/15/2024 | $91,999 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | 2401OHATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 0 | 1 | ACL | 10/30/2023 | $90,074 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | 2401OHATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 1 | 1 | ACL | 12/12/2023 | $144,557 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03AI182416 | Generation of an ILC3-specific Cre driver in mice | 000 | 1 | NIH | 1/29/2024 | $70,875 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL164443 | SLC29A3 lysosomal transporter in hematopoietic homeostasis and disease | 000 | 1 | NIH | 2/8/2024 | $393,750 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R34EY035783 | Identification of School-age Eye conditions Evaluation (ISEE) | 000 | 1 | NIH | 2/21/2024 | $267,006 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F30AI172189 | The Ikaros zinc finger transcription factor Eos as a candidate regulator of TH2 differentiation and effector function | 000 | 1 | NIH | 12/5/2023 | $42,794 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA286017 | ROLES AND MECHANISMS OF TERTIARY LYMPHOID STRUCTURES IN ANTI-TUMOR IMMUNITY | 000 | 1 | NIH | 1/1/2024 | $404,798 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03CA280007 | A sensitivity analysis framework for generalizing randomized clinical trial results in the presence of unmeasured treatment effect modifiers | 000 | 1 | NIH | 12/29/2023 | $90,722 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL168045 | Therapeutic Strategies to Mitigate Toxicities of Anthracycline-Based Therapeutics | 000 | 1 | NIH | 12/20/2023 | $657,529 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31ES036102 | The role of endogenous docosahexaenoic acid in resolving ozone induced lung inflammation | 001 | 1 | NIH | 2/9/2024 | $0 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31ES036102 | The role of endogenous docosahexaenoic acid in resolving ozone induced lung inflammation | 000 | 1 | NIH | 2/9/2024 | $42,794 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL166520 | Transcriptional Coordination and Gene Regulation by MED12 in the Cardiomyocyte | 000 | 2 | NIH | 4/19/2024 | $532,555 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21AG078258 | E-PROOF: E-intervention for Protein Intake and Resistance Training to Optimize Function | 000 | 2 | NIH | 1/24/2024 | $177,188 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA279707 | Contributions of the Adipose Tissue to the Development of Pancreatic Cancer | 000 | 1 | NIH | 2/8/2024 | $506,842 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL168728 | Atrial and blood JNK in Postoperative AF | 000 | 8 | NIH | 3/1/2024 | $616,206 |
| 2024 | 2024 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | K01AA030325 | Socio-cultural and community risk and resilience for alcohol related problems in youth | 002 | 3 | NIH | 4/22/2024 | $146,218 |
|